Amgen Inc. said Brian Druker was elected to the board at the company's annual general meeting.
The Thousand Oaks, Calif.-based company also said that David Baltimore and François de Carbonnel retired from the board.
Following the election and retirements of directors, the number of Amgen board members currently stands at 13.
Also at the meeting, a stockholders proposal for an annual report on the extent to which risks related to public concern over drug pricing strategies are integrated into the company's executive incentive compensation did not pass.
